Industry News
Fusobacterium Linked To Colorectal Cancer
Oct 18, 2011
According to two new investigations published online in Genome Research , independent investigation teams have for the first time discovered a specific microorganism called Fusobacterium to be linked with human colorectal cancer. The discovery of the bacterium in colon cancer tissue could help to pave the way for new diagnosis and treatment strategies of the cancer... Read More
Researchers Find Possible Link Between Bacterium And Colon Cancer
Oct 18, 2011
Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it... Read More
Ginger Root Worth Investigating As Potential Colon Cancer Preventer
Oct 18, 2011
Ginger root supplement is worth investigating as a potential strategy for colon cancer prevention, according to a phase II study published in the 11 October issue of Cancer Prevention Research... Read More
Researchers Find Possible Link Between Bacterium And Colon Cancer
Oct 18, 2011
Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it... Read More
Hair Salons Actively Looking Out For Skin Cancer On Customers
Oct 18, 2011
A number of hair professionals in hairdressing salons are actively checking their customers' scalp, neck and face for signs of skin cancer lesions, researchers from Brigham and Women's Hospital and Harvard School of Public Health, Boston, reported in Archives of Dermatology... Read More
Lung Cancer Patients With Diabetes Live Longer Than Those Without
Oct 17, 2011
Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a new study from Norway due to be published in the November issue of the Journal of Thoracic Oncology... Read More
Primary Bowel Cancer - FDG PET-CT Technology Use Not Cost Effective
Oct 15, 2011
According to a study published in Health Technology Assessment, there is little evidence to support the use of PET-CT add-on imaging device in the pre-operative staging of bowel cancer. Over one million people are diagnosed with colorectal cancer worldwide each year, making it the third most common cancer in the UK after lung and breast cancer... Read More
Yervoy (ipilimumab) Turned Down By UK Watchdog
Oct 15, 2011
The National Institute for Clinical Excellence (NICE) has recommended in a draft guidance against Bristol-Myers Squibb's Yervoy (ipilimumab) for the treatment of advanced malignant melanoma in patients who have already been treated with chemotherapy... Read More
BRCA2 Genetic Mutation Associated With Improved Survival And Chemotherapy Response In Ovarian Cancer
Oct 12, 2011
Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA wild-type (genetic type used as a reference to compare genetic mutations), according to a study in the October 12 issue of JAMA... Read More
Ovarian Cancer Patients Survive Longer With BRCA2 Mutated In Tumors
Oct 12, 2011
Women with high-grade ovarian cancer live longer and respond better to platinum-based chemotherapy when their tumors have BRCA2 genetic mutations, researchers at The University of Texas MD Anderson Cancer Center and the Institute for Systems Biology report in the Oct. 12 issue of the Journal of the American Medical Association... Read More
Previous Page Next Page